Implanet has enrolled the first patient in a multicentre clinical protocol designed to study the medical value provided by the JAZZ Band in the treatment of instrumented thoracic and lumbar arthrodesis (osteodegenerative bone pathologies).
Ludovic Lastennet, chief executive officer of Implanet, says: “We are pleased to announce that the first patient has been enrolled in a multicentre study led by principal investigator H. Francis Farhadi, of The Ohio State University. The study will examine the JAZZ Band as an adjunct to spinal fusion in adult scoliosis and adult degenerative surgeries.”
Farhadi comments: “We are excited to have started the JAZZ Band study and look forward to analysing the potential clinical and economic benefits of sublaminar band technology in complex spinal fusions.”
Patient recruitment will continue, with additional centres joining the study in the second half of 2015.